[
  {
    "id": "1756323452344-p3fm",
    "title": "Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors",
    "date": "2025-08-27T19:37:32.344Z",
    "summary": "Eli Lilly's stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street.",
    "sourceHost": "cnbc.com",
    "sourceUrl": "https://www.cnbc.com/2025/08/24/eli-lilly-oral-obesity-pill-novo-nordisk.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-7c1bby.md"
  },
  {
    "id": "1756323451059-51r2",
    "title": "Mounjaro Vs Ozempic Weight Loss [MGDB75481] Motivational Quotes To Loss Weight",
    "date": "2025-08-27T19:37:31.059Z",
    "summary": "Mounjaro Vs Ozempic Weight Loss Despite its high-quality ingredients and impressive results, Mitolyn is priced competitively, making it accessible to a wide range of consumers Healthy Overnight Oats Recipe For Weight Loss [IZXV21634] Mitolyn is suitable for all skin types and can be incorporated into any skincare routine This ingredient works to plump and moisturize the skin, giving it a youthful and radiant appearance Unlike heavier creams and serums, Mitolyn absorbs quickly into the skin, leaving no greasy residue behind Mounjaro Alternatives For Weight Loss",
    "sourceHost": "gwa-prod-pxm-api.s3.amazonaws.com",
    "sourceUrl": "https://gwa-prod-pxm-api.s3.amazonaws.com/weightloss-lose-weight/WeightLossLaxatives-dak17.html?RuTGcUAG=RuTGcUAG",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-zomyrp.md"
  },
  {
    "id": "1756323450099-csmh",
    "title": "Mounjaro prices - Irish Mammies & Mammies to be",
    "date": "2025-08-27T19:37:30.099Z",
    "summary": "Has anyone seen anything about uk prices rising? I presume this will affect mybmi as it’s Northern Ireland? I know lots of you get it from there.",
    "sourceHost": "community.whattoexpect.com",
    "sourceUrl": "https://community.whattoexpect.com/forums/irish-mammies-mammies-to-be/topic/mounjaro-prices-172052037.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-9mp7wz.md"
  },
  {
    "id": "1756323448633-t3ff",
    "title": "Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026",
    "date": "2025-08-27T19:37:28.633Z",
    "summary": "Eligible for a Bard PowerPort lawsuit? About Lawsuits\n\nSuboxone Tooth Decay\n\nDepo-Provera\n\nOzempic Wegovy and Mounjaro\n\nBard PowerPort\n\nJury trials will continue throughout next year, to help parties negotiate a potential Bard PowerPort lawsuit settlement that may resolve similar claims. Add Your Comments\n\nThe U.",
    "sourceHost": "aboutlawsuits.com",
    "sourceUrl": "https://www.aboutlawsuits.com/bard-powerport-lawsuit/bard-powerport-lawsuit-bellwether-trials-march-2-2026/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-4r30ad.md"
  },
  {
    "id": "1756323446890-jlct",
    "title": "Meghan Trainor Seemingly Shades Social Media Followers",
    "date": "2025-08-27T19:37:26.890Z",
    "summary": "Beauty\n\nSteal Taylor's Engagement Look For Less—We Found Affordable Dupes That Nail Her Effortless Style\n\nCelebrity\n\nSocial Media Calls Out Serena Williams For Endorsing Weight Loss Drug Company Her Husband Is On The Board Of: 'Shame On You Both! '\n\nCelebrity\n\nHailey Bieber Puts On A Leggy Display In Sheer Tights For YSL's Latest Campaign As Fans React: She ‘Looks Gorgeous’\n\nCelebrity\n\nMeghan Trainor has been a busy woman over the last year, putting out new music, recording podcast episodes, and giving live performances. However, she has mostly been making headlines after losing a drastic amount of weight.",
    "sourceHost": "shefinds.com",
    "sourceUrl": "https://www.shefinds.com/collections/meghan-trainor-weight-loss-medication-social-media-response/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-nlk32u.md"
  },
  {
    "id": "1756323445408-ruc5",
    "title": "Panic buying triggers Mounjaro shortage across UK",
    "date": "2025-08-27T19:37:25.408Z",
    "summary": "Share article\n\nMajor UK pharmacy chains are experiencing nationwide shortages of the weight-loss drug Mounjaro after manufacturer Eli Lilly announced a 170 per cent price increase effective September. The highest dose will rise from £122 to £330 per month, triggering panic buying across the country. Superdrug, Boots, and Lloyds Pharmacy are all reporting stock shortages as patients rush to stockpile supplies before the price hike takes effect.",
    "sourceHost": "upday.com",
    "sourceUrl": "https://www.upday.com/uk/uknews/panic-buying-triggers-mounjaro-shortage-across-uk/k5zkzzd",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-jpwv2d.md"
  },
  {
    "id": "1756323444243-rlne",
    "title": "Vet explains how to manage your pet's weight amid 'doggy Mounjaro' plans",
    "date": "2025-08-27T19:37:24.243Z",
    "summary": "The UK has a worrying problem with podgy pets. Half of dogs in Britain and 43 per cent of cats are classified as overweight. But while Mounjaro for people rolled out on the NHS earlier this year, we could be seeing similar weight loss meds for our furry friends soon.",
    "sourceHost": "dailyrecord.co.uk",
    "sourceUrl": "https://www.dailyrecord.co.uk/lifestyle/vet-explains-how-manage-your-35802378",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-m2roqo.md"
  },
  {
    "id": "1756323442937-smf3",
    "title": "Mounjaro helped mum lose 5 stone and ditch shopping addiction",
    "date": "2025-08-27T19:37:22.937Z",
    "summary": "A mother who shed five stone in just five months using weight loss injections claims the treatment has also helped curb her £500-a-month shopping habit. Donique Wint, 38, weighed in at a hefty 18 stone after years of indulging in Nando's and Haribo sweets took their toll.",
    "sourceHost": "uk.news.yahoo.com",
    "sourceUrl": "https://uk.news.yahoo.com/mounjaro-helped-mum-lose-5-194423675.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-bmrus7.md"
  },
  {
    "id": "1756323441731-wrcq",
    "title": "LATEST: DH reveals new Mounjaro NHS reimbursement prices",
    "date": "2025-08-27T19:37:21.731Z",
    "summary": "Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a master’s in journalism at City, University of London. She previously worked as a news reporter at the U.S. Sun, covering business and politics, among other things.",
    "sourceHost": "chemistanddruggist.co.uk",
    "sourceUrl": "https://www.chemistanddruggist.co.uk/news/funding/latest-dh-reveals-new-mounjaro-nhs-reimbursement-prices-F5RGTAUMHNAN5IQVPNPE2SW75Q/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-z5u2iw.md"
  },
  {
    "id": "1756323440640-jmqs",
    "title": "The Sun",
    "date": "2025-08-27T19:37:20.640Z",
    "summary": "Attention,\n\nOur system has indicated that your user behaviour is potentially automated. News Group Newspapers Limited does not permit the access, collection, text or data mining of any content from our Service by any automated means whether directly or through an intermediary service. This is stated in our terms and conditions.",
    "sourceHost": "thesun.co.uk",
    "sourceUrl": "https://www.thesun.co.uk/health/36461078/mounjaro-frozen-tonight-panic-buy-price-hike/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-efcpzk.md"
  },
  {
    "id": "1756323439483-f3do",
    "title": "Warning of nationwide Mounjaro weight-loss jab shortage ahead of UK price hike",
    "date": "2025-08-27T19:37:19.483Z",
    "summary": "Notifications can be managed in browser preferences. Next article\n\nA spike in sales of the weight-loss drug Mounjaro has led to a shortage at major pharmacies, including high street firms Boots, Lloyds Pharmacy and Superdrug. The surge in demand comes after Eli Lilly, which manufactures Mounjaro, announced it was to increase the price of the medication in the UK by 170 per cent from September.",
    "sourceHost": "independent.co.uk",
    "sourceUrl": "https://www.independent.co.uk/news/uk/home-news/mounjaro-weight-loss-drugs-superdrug-pharmacy-b2815006.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-4olsk0.md"
  },
  {
    "id": "1756323438763-nbrq",
    "title": "Patients struggle to get weight loss drug ahead of price rise",
    "date": "2025-08-27T19:37:18.764Z",
    "summary": "Some patients taking the weight-loss drug Mounjaro have told BBC News they are struggling to obtain the medicine, and are worried about the impact on their health.",
    "sourceHost": "bbc.com",
    "sourceUrl": "https://www.bbc.com/news/articles/clyr8ynx41yo",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-0mitk2.md"
  },
  {
    "id": "1756323437859-1qdh",
    "title": "Serena Williams lost 14kg—here’s what GLP-1 injections really do and the 5 risks to watch out for",
    "date": "2025-08-27T19:37:17.859Z",
    "summary": "These injections aren't completely without risks\n\nRecently, tennis legend Serena Williams opened up about using weight-loss medication, aiming to break the ‘stigma’ around such treatments. The 43-year-old, who has won 23 Grand Slam titles and is the epitome of athleticism, admits that after having children, she struggled to shed the extra pounds—just like many of us. Speaking to the Today Show in the US, Williams described her extra weight as “an opponent.",
    "sourceHost": "gulfnews.com",
    "sourceUrl": "https://gulfnews.com/lifestyle/health-fitness/inside-serena-williams-14kg-weight-loss-how-glp-1-injections-work-and-5-side-effects-to-know-1.500244395",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-5anwy5.md"
  },
  {
    "id": "1756323435558-tpgw",
    "title": "Serena Williams’s GLP-1s partnership marks a disturbing cultural turning point",
    "date": "2025-08-27T19:37:15.558Z",
    "summary": "Notifications can be managed in browser preferences. Next article\n\nWeight-loss drugs have their first global ambassador: Serena Williams. The tennis great has signed on as the face of Ro, a telehealth company prescribing GLP-1 weight loss drugs, and where her husband, Alexis Ohanian, is a board member.",
    "sourceHost": "the-independent.com",
    "sourceUrl": "https://www.the-independent.com/voices/serena-williams-glp1-weight-loss-drugs-ro-alexis-ohanian-b2813255.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-sdxcfj.md"
  },
  {
    "id": "1756323434541-ibm9",
    "title": "GLP-1 drugs dominate prescription TV ad spend",
    "date": "2025-08-27T19:37:14.541Z",
    "summary": "Key stat: GLP-1 medications accounted for $360.9 million, or 35.7%, of the top 10 prescription linear TV ad spending in H1 2025, according to a July iSpot.tv report.",
    "sourceHost": "emarketer.com",
    "sourceUrl": "https://www.emarketer.com/content/glp-1-drugs-dominate-prescription-tv-ad-spend",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-26n5hg.md"
  },
  {
    "id": "1756323433633-qw2g",
    "title": "Serena Williams lost 14 kg using GLP-1 drug: 8 things to know about the weight loss medication",
    "date": "2025-08-27T19:37:13.633Z",
    "summary": "Tennis champion Serena Williams has caused a stir after revealing that using GLP-1 medication has been key to her weight-loss journey. After two pregnancies, she found it hard to return to a healthy weight despite rigorous diet and training. The 43-year-old, who has reduced 31 lbs, is one of the many global celebrities, including the likes of Sharon Osbourne, Rebel Wilson and Lizzo. Serena's admission has sparked mixed reactions from the medical community and the Internet alike. Let us tell you 10 most important things to know about GLP-1 drugs.",
    "sourceHost": "hindustantimes.com",
    "sourceUrl": "https://www.hindustantimes.com/lifestyle/health/serena-williams-lost-14-kg-using-glp-1-drug-8-things-to-know-about-the-weight-loss-medication-101756046354195.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-35n6gu.md"
  },
  {
    "id": "1756323432706-m596",
    "title": "Ozempic teeth: Dentists warn of new GLP-1 side effect",
    "date": "2025-08-27T19:37:12.706Z",
    "summary": "Related video: So, you’ve lost weight using Wegovy. Does that mean you can stop taking it? (AP)\n\nPatients using Ozempic and other GLP-1 drugs are reporting a complication not listed among the drug’s most common side effects.",
    "sourceHost": "ca.news.yahoo.com",
    "sourceUrl": "https://ca.news.yahoo.com/ozempic-teeth-dentists-warn-glp-184445013.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-aj6d97.md"
  },
  {
    "id": "1756323431625-povh",
    "title": "The controversy around Serena Williams' weight loss is more nuanced than you may think",
    "date": "2025-08-27T19:37:11.625Z",
    "summary": "Linah Mohammad\n\nJuana Summers\n\nJeanette Woods\n\nThe tennis legend is back in the news - but not for her prowess on the court. Why the controversy around her weight loss is more nuanced than you think. JUANA SUMMERS, HOST:\n\nTennis legend Serena Williams is making headlines again, but this time, it's not about her dominance on the court.",
    "sourceHost": "npr.org",
    "sourceUrl": "https://www.npr.org/2025/08/25/nx-s1-5511375/the-controversy-around-serena-williams-weight-loss-is-more-nuanced-than-you-may-think",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-zx60oh.md"
  },
  {
    "id": "1756323430083-la4u",
    "title": "Eli Lilly could bring first widely available GLP‑1 pill for obesity, diabetes to market this year",
    "date": "2025-08-27T19:37:10.083Z",
    "summary": "Eli Lilly, in the race to develop the first major oral GLP‑1 drug for weight loss, says its pill orforglipron will be submitted for approval this year after a Phase 3 study found it delivered double-digit weight loss in people with Type 2 diabetes.",
    "sourceHost": "scrippsnews.com",
    "sourceUrl": "https://www.scrippsnews.com/health/medicine/eli-lilly-could-bring-first-widely-available-glp-1-pill-for-obesity-diabetes-to-market-this-year",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-g49p7g.md"
  },
  {
    "id": "1756323429051-j3yc",
    "title": "Lilly readies its first weight loss drug pill for approval",
    "date": "2025-08-27T19:37:09.051Z",
    "summary": "The news: Eli Lilly plans to file for global regulatory approval of its first weight loss pill following positive results in a second key trial. People with both obesity and type 2 diabetes lost an average 10.5% of their weight and significantly improved blood sugar levels.",
    "sourceHost": "emarketer.com",
    "sourceUrl": "https://www.emarketer.com/content/eli-lilly-moves-file-approval-of-glp-1-weight-loss-pill",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-yym5qf.md"
  },
  {
    "id": "1756323427982-f67c",
    "title": "GLP-1 Indications Continue to Expand: Potential approvals expected through 2026",
    "date": "2025-08-27T19:37:07.982Z",
    "summary": "ARTICLES / AUGUST 26, 2025\n\nFollowing other expanded indications (opens a new window) for GLP-1s, Wegovy has now received FDA approval for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis. This marks a significant expansion in the therapeutic landscape for GLP-1s, highlighting their growing role in addressing complex metabolic conditions. The growing GLP-1 approval pipeline has significant implications for employers in terms of cost, coverage, and employee access.",
    "sourceHost": "global.lockton.com",
    "sourceUrl": "https://global.lockton.com/us/en/news-insights/glp-1-indications-continue-to-expand-potential-approvals",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ginj1y.md"
  },
  {
    "id": "1756323427027-fcqf",
    "title": "Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity",
    "date": "2025-08-27T19:37:07.027Z",
    "summary": "Oops, something went wrong\n\nWe are experiencing some temporary issues. The market data on this page is currently delayed. In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent with injectable GLP-1 medicines\n\nParticipants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 22.",
    "sourceHost": "finance.yahoo.com",
    "sourceUrl": "https://finance.yahoo.com/news/lillys-oral-glp-1-orforglipron-104500826.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-6zrc53.md"
  },
  {
    "id": "1756323424962-rr8z",
    "title": "Eli Lilly GLP-1 pill shows promising weight loss in type 2 diabetes trial",
    "date": "2025-08-27T19:37:04.962Z",
    "summary": "Eli Lilly LLY.N said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in patients without diabetes sent company shares tumbling.",
    "sourceHost": "usatoday.com",
    "sourceUrl": "https://www.usatoday.com/story/news/health/2025/08/26/lilly-glp-1-pill-weight-loss/85830686007/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-9o7mcu.md"
  },
  {
    "id": "1756323424121-fpum",
    "title": "Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval",
    "date": "2025-08-27T19:37:04.121Z",
    "summary": "In this article\n\nEli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study's main goal and clearing the way for the company to file for approval of the drug globally. The treatment is inching closer to becoming a new, needle-free alternative in the highly lucrative market for weight loss and diabetes drugs called GLP-1s. More convenient pills could boost supply for the treatments and make them easier to access than the pricey weekly injections currently dominating the space.",
    "sourceHost": "cnbc.com",
    "sourceUrl": "https://www.cnbc.com/2025/08/26/eli-lilly-weight-loss-pill-orforglipron-clears-trial-paving-way-for-approval.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-zv0inf.md"
  },
  {
    "id": "1756323423213-v4md",
    "title": "Lilly rounds out oral GLP-1 approval bid with phase 3 obesity win for patients with diabetes",
    "date": "2025-08-27T19:37:03.213Z",
    "summary": "After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s chances of securing a green light in obesity.",
    "sourceHost": "fiercebiotech.com",
    "sourceUrl": "https://www.fiercebiotech.com/biotech/lilly-rounds-out-oral-glp-1-approval-bid-ph-3-win-patients-obesity-and-diabetes",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-kqgocn.md"
  },
  {
    "id": "1756323416733-biwe",
    "title": "New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval",
    "date": "2025-08-27T19:36:56.733Z",
    "summary": "The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday.",
    "sourceHost": "cnn.com",
    "sourceUrl": "https://www.cnn.com/2025/08/26/health/glp-1-pill-eli-lilly",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-v480oq.md"
  },
  {
    "id": "1756323415532-jzrz",
    "title": "Eli Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds",
    "date": "2025-08-27T19:36:55.532Z",
    "summary": "Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 pounds or more than 10% of their body weight on average, according to new data released Tuesday morning. Eli Lilly said the oral GLP-1 pill has been shown to reduce hemoglobin A1C levels -- a blood test that shows average blood sugar levels over two to three months -- by an average of 1.",
    "sourceHost": "abcnews.go.com",
    "sourceUrl": "https://abcnews.go.com/GMA/Wellness/eli-lillys-oral-glp-1-pill-people-type/story?id=124963525",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-g8qy93.md"
  },
  {
    "id": "1756323414725-9vk2",
    "title": "Our Phase 3 ATTAIN-2 study demonstrated that an oral GLP-1 has the potential to achieve weight loss consistent with injectables in patients with both diabetes and obesity — a population where weight…",
    "date": "2025-08-27T19:36:54.725Z",
    "summary": "Chief Scientific Officer and President, Lilly Research Laboratories; President, Immunology at Eli Lilly and Company\n\nOur Phase 3 ATTAIN-2 study demonstrated that an oral GLP-1 has the potential to achieve weight loss consistent with injectables in patients with both diabetes and obesity — a population where weight loss has historically been most challenging. The results showed meaningful weight reduction and A1C improvements, with the majority of patients reaching below-diabetes thresholds. All from a once-daily pill with no food or water restrictions.",
    "sourceHost": "linkedin.com",
    "sourceUrl": "https://www.linkedin.com/posts/danielskovronsky_our-phase-3-attain-2-study-demonstrated-that-activity-7366123120128081920-1Olh",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-qr91vx.md"
  },
  {
    "id": "1756323413460-0x5a",
    "title": "Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity",
    "date": "2025-08-27T19:36:53.460Z",
    "summary": "In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent with injectable GLP-1 medicines",
    "sourceHost": "investor.lilly.com",
    "sourceUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-successful-third-phase-3-trial",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-wi7a3j.md"
  },
  {
    "id": "1756323382422-qo4b",
    "title": "New Weight Loss Drug Outperformed Existing Treatment in Clinical Trial",
    "date": "2025-08-27T19:36:22.422Z",
    "summary": "Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type 2  diabetes and obesity. After a successful phase 3 trial, a new kind of treatment based on the same mechanics could deliver even more impressive weight-loss results. Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist.",
    "sourceHost": "sciencealert.com",
    "sourceUrl": "https://www.sciencealert.com/new-weight-loss-drug-outperformed-existing-treatment-in-clinical-trial",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-qoqkfv.md"
  },
  {
    "id": "1756323381567-fisu",
    "title": "GLP-1 coverage: A roadmap for balancing cost and care",
    "date": "2025-08-27T19:36:21.567Z",
    "summary": "© Touchpoint Markets, All Rights Reserved. Request academic re-use from\n    www. copyright.",
    "sourceHost": "benefitspro.com",
    "sourceUrl": "https://www.benefitspro.com/2025/08/25/glp-1-coverage-a-roadmap-for-balancing-cost-and-care/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-bb2esd.md"
  },
  {
    "id": "1756323380601-ja48",
    "title": "Actress Slams Serena Williams' Weight Loss Drug For Potentially 'Devastating' Side Effects",
    "date": "2025-08-27T19:36:20.601Z",
    "summary": "Serena Williams has been in the news this past week. But this time, it's not because of yet another tennis-related accolade. The former World No.",
    "sourceHost": "yahoo.com",
    "sourceUrl": "https://www.yahoo.com/entertainment/celebrity/articles/actress-slams-serena-williams-weight-014521361.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-1rt4gt.md"
  },
  {
    "id": "1756323379317-sgm3",
    "title": "A world on weight loss drugs: How GLP-1s are reshaping the economy",
    "date": "2025-08-27T19:36:19.317Z",
    "summary": "Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s.",
    "sourceHost": "cnbc.com",
    "sourceUrl": "https://www.cnbc.com/2025/08/26/how-glp-1s-wegovy-zepbound-are-reshaping-the-economy.html",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-8gnswx.md"
  },
  {
    "id": "1756323377702-ii9i",
    "title": "Why Ozempic users 'can barely finish a third' of their restaurant orders",
    "date": "2025-08-27T19:36:17.702Z",
    "summary": "Restaurateur and media personality Max Tucci discusses how his New York City restaurant, Tucci, is offering meals catering to users of weight-loss drugs on 'Fox & Friends Weekend.'",
    "sourceHost": "foxnews.com",
    "sourceUrl": "https://www.foxnews.com/food-drink/ozempic-users-can-barely-finish-third-restaurant-orders",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-c4pocc.md"
  },
  {
    "id": "1756323376935-k3bn",
    "title": "GLP-1s: A weight loss ‘staple’ in American homes",
    "date": "2025-08-27T19:36:16.935Z",
    "summary": "© Touchpoint Markets, All Rights Reserved. Request academic re-use from\n    www. copyright.",
    "sourceHost": "benefitspro.com",
    "sourceUrl": "https://www.benefitspro.com/2025/08/25/glp-1s-a-weight-loss-staple-in-american-homes/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-7rnoyj.md"
  },
  {
    "id": "1756323376008-1nz2",
    "title": "GLP-1 Titration Remains Persistent Challenge Among Patients With Obesity",
    "date": "2025-08-27T19:36:16.008Z",
    "summary": "Researchers explored the real-world dose titration, adherence rates, and effectiveness of glucagon-like peptide-1 medications among patients in a multidisciplinary obesity clinic.",
    "sourceHost": "drugtopics.com",
    "sourceUrl": "https://www.drugtopics.com/view/glp-1-titration-remains-persistent-challenge-among-patients-with-obesity",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-vxjdus.md"
  },
  {
    "id": "1756323373252-4lqz",
    "title": "GLP-1s May Lower the Risk of Obesity-Related Cancers, Study Finds",
    "date": "2025-08-27T19:36:13.252Z",
    "summary": "[1]\n\nResearchers looked at the rates of lung cancer plus more than a dozen obesity-related cancers and found that people taking GLP-1s had a reduced overall risk of cancer compared with those not taking the drugs — particularly for ovarian and endometrial cancers and some brain tumors. “Obesity is one of the strongest risk factors for cancer, yet we’ve had very little data on whether new obesity drugs affect cancer risk,” says the senior study author, Serena Jingchuan Guo, MD, PhD, an associate professor and the AI director at the Purdue University College of Pharmacy in Indiana. “With GLP-1 medicines being used by millions of people today, it was the right time to ask this question.",
    "sourceHost": "everydayhealth.com",
    "sourceUrl": "https://www.everydayhealth.com/cancer/weight-loss-drugs-may-reduce-the-risk-of-some-cancers/",
    "mdUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-gjy30n.md"
  },
  {
    "title": "Vzestup celebritních endorsementů v oblasti farmacie a jejich dopady",
    "sourceUrl": "https://www.webpronews.com/serena-williams-reveals-glp-1-use-for-postpartum-weight-loss-faces-backlash/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-1jm4mh.md",
    "date": "2025-08-27"
  },
  {
    "title": "Ecnoglutid jako nová účinná léčba diabetu 2. typu s lepší kontrolou glykémie a váhy",
    "sourceUrl": "https://www.sciencedirect.com/science/article/abs/pii/S2213858725001962",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-k6lgbl.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams jako ambasadorka GLP-1 léčby u Ro",
    "sourceUrl": "https://femtechinsider.com/serena-williams-ro-and-the-uneasy-promise-of-celebrity-backed-glp-1-campaigns/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-4vvirq.md",
    "date": "2025-08-27"
  },
  {
    "title": "Pozitivní účinky GLP-1 léků na zdraví a kvalitu života pacientů",
    "sourceUrl": "https://www.aol.com/lifestyle/too-young-waking-pain-glp-090033409.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ik45qo.md",
    "date": "2025-08-27"
  },
  {
    "title": "GLP-1 receptor agonisté v léčbě Parkinsonovy nemoci: přehled a metaanalýza",
    "sourceUrl": "https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-025-01888-1",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-th451u.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: thehill.com",
    "sourceUrl": "https://thehill.com/policy/healthcare/5467385-ozempic-teeth-new-side-effect-weightloss-drugs/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-vtqpf3.md",
    "date": "2025-08-27"
  },
  {
    "title": "Studie zjistila snížení rizika rakoviny u uživatelů léků GLP-1 na hubnutí",
    "sourceUrl": "https://oncodaily.com/science/glp-1-receptor-agonists-353999",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-r9w6ki.md",
    "date": "2025-08-27"
  },
  {
    "title": "Metabolický syndrom a riziko rychlého jedení pro zdraví",
    "sourceUrl": "https://nypost.com/2025/08/22/health/common-mistake-can-mess-with-bodys-natural-ozempic-hormones-up-diabetes-risk/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-e2uech.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: wane.com",
    "sourceUrl": "https://www.wane.com/news/ozempic-teeth-dentists-warn-of-new-glp-1-side-effect/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-6awch7.md",
    "date": "2025-08-27"
  },
  {
    "title": "Eli Lilly zvyšuje cenu léku Mounjaro v UK až o 170 procent",
    "sourceUrl": "https://www.lbc.co.uk/article/lib-dems-watchdog-mounjaro-sales-suspended-5HjdBXR_2/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-64q6jv.md",
    "date": "2025-08-27"
  },
  {
    "title": "Clinton Hall nabízí mini jídla pro hosty užívající Ozempic a podobné léky",
    "sourceUrl": "https://tribecacitizen.com/2025/08/27/in-the-news-7/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-37tp8g.md",
    "date": "2025-08-27"
  },
  {
    "title": "Nemocniční lékárenství a farmaceutická péče v ČR",
    "sourceUrl": "https://www.chemistanddruggist.co.uk/news/clinical/online-pharmacies-see-mounjaro-stock-shortages-amid-price-hike-DCD7L3VLRNHOJDBA5ITYD22X4I/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-pq62wx.md",
    "date": "2025-08-27"
  },
  {
    "title": "Mounjaro (Tirzepatid) zdraží od září 2025 v UK, NHS ceny se přizpůsobí",
    "sourceUrl": "https://www.thepharmacist.co.uk/clinical/nutrition-and-gastroenterology/mounjaro-nhs-reimbursement-agreement-in-place-for-september/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-81onf5.md",
    "date": "2025-08-27"
  },
  {
    "title": "Rychlý růst spotřeby a nákladů na léky GLP-1 v USA",
    "sourceUrl": "https://www.ama-assn.org/public-health/prevention-wellness/spending-glp-1s-has-grown-dramatically-here-are-details",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-8t5oi0.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: business-standard.com",
    "sourceUrl": "https://www.business-standard.com/health/serena-williams-glp1-drugs-weight-loss-ozempic-zepbound-fitness-125082500636_1.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-vorwlw.md",
    "date": "2025-08-27"
  },
  {
    "title": "New study suggests a link between GLP-1s and lower cancer risk",
    "sourceUrl": "https://www.goodmorningamerica.com/wellness/video/new-study-suggests-link-glp-1sand-lower-cancer-124929714",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-86y9nr.md",
    "date": "2025-08-27"
  },
  {
    "title": "MSN",
    "sourceUrl": "http://www.msn.com/en-us/sports/nba/serena-williams-reveals-the-real-reason-why-she-used-glp-1-medication-to-lose-weight/ar-AA1L2ATN?apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-5egxn8.md",
    "date": "2025-08-27"
  },
  {
    "title": "Shrnutí článku",
    "sourceUrl": "https://firstwordpharma.com/story/5991600",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-iun77c.md",
    "date": "2025-08-27"
  },
  {
    "title": "Protizánětlivé účinky agonistů GLP-1 a jejich vliv na metabolická onemocnění",
    "sourceUrl": "https://www.cureus.com/articles/403226-glucagon-like-peptide-1-glp-1-receptor-agonist-use-and-inflammatory-markers-among-us-adults-a-national-health-and-nutrition-examination-survey-nhanes-based-analysis?score_article=true",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ptory3.md",
    "date": "2025-08-27"
  },
  {
    "title": "Noom Microdose GLP-1 program pro hubené s nižšími dávkami a vedlejšími účinky",
    "sourceUrl": "https://www.medicalnewstoday.com/articles/glp-1-microdosing-for-weight-loss-experts-weigh-the-pros-and-cons",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-lpij4d.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: m.facebook.com",
    "sourceUrl": "https://m.facebook.com/JuliaSamuelMBE/videos/the-truth-behind-body-image-and-quick-fixes-ozempic-mounjaro-they-promise-the-bo/1057939986368656/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-mjalbs.md",
    "date": "2025-08-27"
  },
  {
    "title": "Přístup k GLP-1 receptorovým agonistům u dospívajících a mladých dospělých",
    "sourceUrl": "https://www.gastroenterologyadvisor.com/news/study-ids-barriers-to-glp-1-receptor-agonist-use-in-adolescents-young-adults/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-xxh4mg.md",
    "date": "2025-08-27"
  },
  {
    "title": "Cena léku Mounjaro v UK vzroste až o 170 % od září 2025",
    "sourceUrl": "https://www.theguardian.com/business/2025/aug/14/eli-lilly-uk-price-weight-loss-jab-mounjaro-trump",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-hvrwpa.md",
    "date": "2025-08-27"
  },
  {
    "title": "Nebezpečí a rizika nelegálních GLP-1 léků na hubnutí",
    "sourceUrl": "https://www.everydayhealth.com/weight-management/fda-raises-safety-concerns-with-compounded-glp-1-weight-loss-drugs/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-9mpg1j.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: finance.yahoo.com",
    "sourceUrl": "https://finance.yahoo.com/news/eli-lilly-raising-glp-1-prices-abroad-raises-more-questions-about-us-pricing-bofa-analyst-191601993.html",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ci8iet.md",
    "date": "2025-08-27"
  },
  {
    "title": "MSN",
    "sourceUrl": "https://www.msn.com/en-us/health/other/staggeringly-high-discontinuation-rates-for-glp-1-drugs-like-ozempic-or-wegovy/ar-AA1uj3OS?apiversion=v2",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-d329xl.md",
    "date": "2025-08-27"
  },
  {
    "title": "GLP-1 agonisté: účinky, rozdíly a vedlejší účinky nových léků na diabetes a obezitu",
    "sourceUrl": "http://uknow.uky.edu/uk-healthcare/new-generation-weight-loss-drugs-pros-and-cons-glp-1s",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-ge9ys5.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: qz.com",
    "sourceUrl": "https://qz.com/novo-nordisk-stock-pops-discount-ozempic-cash",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-zimh1v.md",
    "date": "2025-08-27"
  },
  {
    "title": "Jak posilovat svaly při užívání léků GLP-1 na hubnutí",
    "sourceUrl": "https://www.cnn.com/2025/08/18/health/glp1-muscle-loss-strength-training-wellness",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-9ayj6c.md",
    "date": "2025-08-27"
  },
  {
    "title": "Semaglutid a tirzepatid: rozdíly, dostupnost a bezpečnost léků na hubnutí",
    "sourceUrl": "https://www.nebraskamed.com/health/healthy-lifestyle/bariatrics-weight-loss/what-you-need-to-know-about-the-compounded-glp-1",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-zxlqd0.md",
    "date": "2025-08-27"
  },
  {
    "title": "Používání GLP-1 RA injekcí u dospělých s diabetem v roce 2024",
    "sourceUrl": "https://www.rheumatologyadvisor.com/news/26-5-percent-of-adults-with-diabetes-used-glp-1-ra-injectables-in-2024/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-gl9tez.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams otevřeně o užívání GLP-1 léků na hubnutí",
    "sourceUrl": "https://www.today.com/health/womens-health/serena-williams-glp-1-weight-loss-rcna226141",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-uw3q86.md",
    "date": "2025-08-27"
  },
  {
    "title": "Serena Williams otevřeně o váze a užívání léků na hubnutí po porodu",
    "sourceUrl": "https://www.womenshealthmag.com/uk/fitness/fat-loss/a65862142/serena-williams-weight-loss-glp1-ro/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-h6qnfm.md",
    "date": "2025-08-27"
  },
  {
    "title": "Prodej léku Wegovy v UK vzrostl o 2000 % díky zdražení Mounjaro",
    "sourceUrl": "https://www.ibtimes.co.uk/uk-sales-wegovy-skyrocket-2000-dieters-dump-mounjaro-after-170-price-hike-1742037",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-jemnx9.md",
    "date": "2025-08-27"
  },
  {
    "title": "PressReader.com - Digital Newspaper & Magazine Subscriptions",
    "sourceUrl": "https://www.pressreader.com/usa/the-washington-post-sunday-598/20250824/281904484282452",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-wo0hiu.md",
    "date": "2025-08-27"
  },
  {
    "title": "Terns Pharmaceuticals ukončuje vývoj v oblasti obezity a zaměřuje se na onkologii",
    "sourceUrl": "https://www.biospace.com/drug-development/weight-loss-wasteland-5-obesity-assets-that-failed",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-q50rjj.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: thelancet.com",
    "sourceUrl": "https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00197-4/fulltext?rss=yes",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-cusq8v.md",
    "date": "2025-08-27"
  },
  {
    "title": "Menopauzální hormonální terapie zlepšuje účinnost hubnutí s tirzepatidem",
    "sourceUrl": "https://www.empr.com/news/endo-superior-weight-loss-seen-with-tirzepatide-and-menopausal-hormone-therapy-use/",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-j09m9f.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: pharmacytimes.com",
    "sourceUrl": "https://www.pharmacytimes.com/view/obesity-messaging-glp-1-agonists-and-the-pharmacist-s-ethical-imperative-navigating-a-shifting-landscape",
    "summaryUrl": "https://github.com/OnLi1971/mounjaro-summaries/blob/main/summaries/2025-08-27-2o5jfs.md",
    "date": "2025-08-27"
  },
  {
    "title": "Odkaz: everydayhealth.com",
    "sourceUrl": "https://www.everydayhealth.com/obesity/glp-1-pill-helps-people-with-obesity-lose-thirty-pounds-in-new-trial/",
    "summaryUrl": "https://www.everydayhealth.com/obesity/glp-1-pill-helps-people-with-obesity-lose-thirty-pounds-in-new-trial/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: chiefhealthcareexecutive.com",
    "sourceUrl": "https://www.chiefhealthcareexecutive.com/view/glp-1-drugs-and-those-who-take-them-che-explainer",
    "summaryUrl": "https://www.chiefhealthcareexecutive.com/view/glp-1-drugs-and-those-who-take-them-che-explainer",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: rollingstone.com",
    "sourceUrl": "https://www.rollingstone.com/culture/culture-features/glp1-patches-influencers-ozempic-1235403902/",
    "summaryUrl": "https://www.rollingstone.com/culture/culture-features/glp1-patches-influencers-ozempic-1235403902/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: ift.org",
    "sourceUrl": "https://www.ift.org/news-and-publications/blog/2025/smarter-nutrition-in-the-age-of-glp-1s",
    "summaryUrl": "https://www.ift.org/news-and-publications/blog/2025/smarter-nutrition-in-the-age-of-glp-1s",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: abdpost.com",
    "sourceUrl": "https://www.abdpost.com/travis-barkers-ex-shanna-moakler-flaunts-mounjaro-weight-loss/399095",
    "summaryUrl": "https://www.abdpost.com/travis-barkers-ex-shanna-moakler-flaunts-mounjaro-weight-loss/399095",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: abcnews.go.com",
    "sourceUrl": "https://abcnews.go.com/GMA/Wellness/daily-oral-glp-1-pill-effective-weekly-shots/story?id=124440685",
    "summaryUrl": "https://abcnews.go.com/GMA/Wellness/daily-oral-glp-1-pill-effective-weekly-shots/story?id=124440685",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cnn.com",
    "sourceUrl": "https://www.cnn.com/2025/08/07/health/lilly-glp1-pill-weight-loss",
    "summaryUrl": "https://www.cnn.com/2025/08/07/health/lilly-glp1-pill-weight-loss",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: fiercebiotech.com",
    "sourceUrl": "https://www.fiercebiotech.com/biotech/pfizers-embattled-obesity-program-loses-another-glp-1-drug",
    "summaryUrl": "https://www.fiercebiotech.com/biotech/pfizers-embattled-obesity-program-loses-another-glp-1-drug",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: medicine.yale.edu",
    "sourceUrl": "https://medicine.yale.edu/news-article/new-research-letter-examines-glp-1-access-for-adolescents-and-young-adults/",
    "summaryUrl": "https://medicine.yale.edu/news-article/new-research-letter-examines-glp-1-access-for-adolescents-and-young-adults/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: bbc.com",
    "sourceUrl": "https://www.bbc.com/news/articles/cwy3jg20j1ro",
    "summaryUrl": "https://www.bbc.com/news/articles/cwy3jg20j1ro",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: medicaldialogues.in",
    "sourceUrl": "https://medicaldialogues.in/amp/cardiology-ctvs/news/cardiac-safety-data-of-tirzepatide-released-tirzepatide-offers-additional-cardiac-benefits-over-dulaglutide-in-surpass-cvot-trial-152904",
    "summaryUrl": "https://medicaldialogues.in/amp/cardiology-ctvs/news/cardiac-safety-data-of-tirzepatide-released-tirzepatide-offers-additional-cardiac-benefits-over-dulaglutide-in-surpass-cvot-trial-152904",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: nutritioninsight.com",
    "sourceUrl": "https://www.nutritioninsight.com/news/gut-bacteria-glp-1-fat-loss-blood-sugar",
    "summaryUrl": "https://www.nutritioninsight.com/news/gut-bacteria-glp-1-fat-loss-blood-sugar",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thehill.com",
    "sourceUrl": "https://thehill.com/policy/healthcare/5433642-americans-awareness-weight-loss-drugs-ozempic-wegovy-survey/",
    "summaryUrl": "https://thehill.com/policy/healthcare/5433642-americans-awareness-weight-loss-drugs-ozempic-wegovy-survey/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: hsph.harvard.edu",
    "sourceUrl": "https://hsph.harvard.edu/news/ozempic-wegovy-inspire-wave-of-glp-1-supplements-but-are-they-safe-or-effective/",
    "summaryUrl": "https://hsph.harvard.edu/news/ozempic-wegovy-inspire-wave-of-glp-1-supplements-but-are-they-safe-or-effective/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: statnews.com",
    "sourceUrl": "https://www.statnews.com/2025/08/01/glp-1s-weight-loss-medication-ozempic-access-cost-medicare-medicaid/",
    "summaryUrl": "https://www.statnews.com/2025/08/01/glp-1s-weight-loss-medication-ozempic-access-cost-medicare-medicaid/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: investor.lilly.com",
    "sourceUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated",
    "summaryUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thebody.com",
    "sourceUrl": "https://www.thebody.com/hiv/glp1-inhibitors-hiv-what-you-need-to-know",
    "summaryUrl": "https://www.thebody.com/hiv/glp1-inhibitors-hiv-what-you-need-to-know",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: investors.hims.com",
    "sourceUrl": "https://investors.hims.com/news/news-details/2025/Hims--Hers-Data-Shows-Personalized-GLP-1-Plans-Drive-Real-Weight-Loss-Few-Side-Effects-and-Strong-Adherence-to-Care/default.aspx",
    "summaryUrl": "https://investors.hims.com/news/news-details/2025/Hims--Hers-Data-Shows-Personalized-GLP-1-Plans-Drive-Real-Weight-Loss-Few-Side-Effects-and-Strong-Adherence-to-Care/default.aspx",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thecardiologyadvisor.com",
    "sourceUrl": "https://www.thecardiologyadvisor.com/news/tirzepatide-slows-kidney-decline-in-prediabetes-with-overweight-obesity/",
    "summaryUrl": "https://www.thecardiologyadvisor.com/news/tirzepatide-slows-kidney-decline-in-prediabetes-with-overweight-obesity/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: renalandurologynews.com",
    "sourceUrl": "https://www.renalandurologynews.com/news/cancer-diabetes-t2dm-glp-1ra-improved-survival-patients/",
    "summaryUrl": "https://www.renalandurologynews.com/news/cancer-diabetes-t2dm-glp-1ra-improved-survival-patients/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: news.cuanschutz.edu",
    "sourceUrl": "https://news.cuanschutz.edu/cancer-center/glp-1-drugs-thyroid-cancer",
    "summaryUrl": "https://news.cuanschutz.edu/cancer-center/glp-1-drugs-thyroid-cancer",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: finance.yahoo.com",
    "sourceUrl": "https://finance.yahoo.com/news/could-glp-1-drugs-potentially-131600282.html",
    "summaryUrl": "https://finance.yahoo.com/news/could-glp-1-drugs-potentially-131600282.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: livemint.com",
    "sourceUrl": "https://www.livemint.com/opinion/online-views/ozempic-mounjaro-semaglutide-tirzepatide-appetite-suppression-weight-loss-culture-food-addiction-soylent-exercise-health-11753364865668.html",
    "summaryUrl": "https://www.livemint.com/opinion/online-views/ozempic-mounjaro-semaglutide-tirzepatide-appetite-suppression-weight-loss-culture-food-addiction-soylent-exercise-health-11753364865668.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: renalandurologynews.com",
    "sourceUrl": "https://www.renalandurologynews.com/news/glp-1-receptor-agonists-may-improve-outcomes-in-idiopathic-intracranial-hypertension/",
    "summaryUrl": "https://www.renalandurologynews.com/news/glp-1-receptor-agonists-may-improve-outcomes-in-idiopathic-intracranial-hypertension/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: reddit.com",
    "sourceUrl": "https://www.reddit.com/r/Zepbound/comments/1m8r1cv/zepbound_vs_mounjaro/",
    "summaryUrl": "https://www.reddit.com/r/Zepbound/comments/1m8r1cv/zepbound_vs_mounjaro/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: mercer.com",
    "sourceUrl": "https://www.mercer.com/en-us/insights/us-health-news/glp-1-considerations-for-2026-your-questions-answered/",
    "summaryUrl": "https://www.mercer.com/en-us/insights/us-health-news/glp-1-considerations-for-2026-your-questions-answered/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: news-medical.net",
    "sourceUrl": "https://www.news-medical.net/news/20250723/What-happens-to-your-weight-after-quitting-GLP-1-anti-obesity-drugs.aspx",
    "summaryUrl": "https://www.news-medical.net/news/20250723/What-happens-to-your-weight-after-quitting-GLP-1-anti-obesity-drugs.aspx",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: gastroenterologyadvisor.com",
    "sourceUrl": "https://www.gastroenterologyadvisor.com/news/glp-1-receptor-agonist-use-in-t2d-linked-to-increased-risk-for-gerd-gerd-complications/",
    "summaryUrl": "https://www.gastroenterologyadvisor.com/news/glp-1-receptor-agonist-use-in-t2d-linked-to-increased-risk-for-gerd-gerd-complications/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: newsroom.uvahealth.com",
    "sourceUrl": "https://newsroom.uvahealth.com/2025/07/21/glp-1-drugs-fail-to-provide-key-weight-loss-benefit/",
    "summaryUrl": "https://newsroom.uvahealth.com/2025/07/21/glp-1-drugs-fail-to-provide-key-weight-loss-benefit/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cureus.com",
    "sourceUrl": "https://www.cureus.com/articles/390268-effects-of-tirzepatide-on-low-density-lipoprotein-cholesterol-levels-in-adults-a-systematic-review",
    "summaryUrl": "https://www.cureus.com/articles/390268-effects-of-tirzepatide-on-low-density-lipoprotein-cholesterol-levels-in-adults-a-systematic-review",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cnbc.com",
    "sourceUrl": "https://www.cnbc.com/2025/07/20/weight-loss-drugs-could-help-treat-pcos.html",
    "summaryUrl": "https://www.cnbc.com/2025/07/20/weight-loss-drugs-could-help-treat-pcos.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cureus.com",
    "sourceUrl": "https://www.cureus.com/articles/380767-weight-loss-that-lasts-reviewing-the-long-term-impact-of-glp-1-receptor-agonists",
    "summaryUrl": "https://www.cureus.com/articles/380767-weight-loss-that-lasts-reviewing-the-long-term-impact-of-glp-1-receptor-agonists",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: rheumatologyadvisor.com",
    "sourceUrl": "https://www.rheumatologyadvisor.com/news/certain-factors-may-predict-weight-fluctuations-after-glp-1-receptor-agonist-treatment/",
    "summaryUrl": "https://www.rheumatologyadvisor.com/news/certain-factors-may-predict-weight-fluctuations-after-glp-1-receptor-agonist-treatment/",
    "date": "2025-08-26"
  },
  {
    "title": "nejmJW_1L_RGB-b",
    "sourceUrl": "https://www.jwatch.org/na58926/2025/07/15/new-variations-glp-1-receptor-agonists-are-coming",
    "summaryUrl": "https://www.jwatch.org/na58926/2025/07/15/new-variations-glp-1-receptor-agonists-are-coming",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: dailymail.co.uk",
    "sourceUrl": "https://www.dailymail.co.uk/health/article-14910243/Scientists-discover-new-link-Mounjaro-BREAST-cancer.html",
    "summaryUrl": "https://www.dailymail.co.uk/health/article-14910243/Scientists-discover-new-link-Mounjaro-BREAST-cancer.html",
    "date": "2025-08-26"
  }
]